Medical Weight Loss FAQ'S

Both are injectable GLP-1 medications that promote weight loss, but they work slightly differently. Semaglutide (brand names Wegovy, Ozempic) is a GLP-1 receptor agonist that mimics a hormone that regulates appetite and blood sugar. Tirzepatide (brand names Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist that targets two pathways, often resulting in greater weight loss for some patients. Both are administered as weekly injections. During your consultation, we will review your medical history, weight loss goals, and recommend which medication is best for your individual needs. Some patients achieve excellent results with Semaglutide, while others may benefit from Tirzepatide's dual action.

Weight loss varies by individual, but clinical studies show significant results. Patients on Semaglutide typically lose 10-15% of their body weight over 12-18 months. Tirzepatide patients may lose 15-20% or more of their body weight. For example, someone weighing 200 pounds might lose 20-40 pounds with these medications combined with lifestyle modifications. Results depend on adherence to the medication, dietary changes, physical activity, and individual metabolism. These medications work best when combined with healthy eating habits and regular exercise. During your consultation, we'll discuss realistic expectations based on your starting weight and goals.

Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort, especially when starting treatment or increasing dosage. These typically improve over time as your body adjusts. We start with a low dose and gradually increase to minimize side effects. Less common side effects include fatigue, dizziness, or injection site reactions. Rarely, more serious side effects like pancreatitis, gallbladder problems, or thyroid issues can occur. GLP-1 medications are not recommended for people with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2.

Throughout treatment, Physician Assistant, Tiffany Fluhme monitors your progress, adjusts your plan to minimize side effects, and ensures you're losing weight safely and effectively.

GLP-1 medications are typically continued long-term to maintain weight loss. Clinical studies show that most patients regain weight if they stop the medication, as the hormonal regulation returns to baseline. Think of it like managing blood pressure or cholesterol—ongoing treatment maintains results. However, some patients successfully transition off medication after achieving their goal weight by establishing sustainable healthy eating habits and active lifestyles. The duration of treatment varies by individual. During your program, we will work with you on lifestyle modifications that support long-term weight maintenance, whether you continue medication or eventually transition off under medical supervision.

We do not accept insurance for weight loss medications. Payment is required at the time of service. However, we can provide detailed receipts and documentation that you can submit to your insurance company for potential reimbursement. Some insurance plans may offer partial coverage for GLP-1 medications when prescribed for weight loss, though many do not. During your consultation, we'll discuss pricing and payment options. Our team will provide all necessary documentation to help you seek reimbursement from your insurance if your plan offers any coverage for these medications.